Skip to main content
Premium Trial:

Request an Annual Quote

Richard Moran, William Keane, Thomas Tuschl, Geoffrey Burnstock


Richard Moran has been appointed as senior vice president and CFO of Genta, the company said last week. He succeeds William Keane, who will resign Sept. 23 and will remain a company consultant.

From 2002 until his retirement in 2004, Moran was director for special projects at Johnson and Johnson.

Rockefeller University researcher and RNAi pioneer Thomas Tuschl has won the 2005 Ernst Schering Prize, according to the Ernst Schering Foundation.

He is honored "for his groundbreaking work in the field of RNA interference." Tuschl will receive the award, which comes with €50,000 in prize money, at a ceremony in Berlin on Sept. 21.

Geoffrey Burnstock has joined the scientific advisory board of CytRx, the company said this week.

Burnstock is a professor and director of the Autonomic Neuroscience Institute at the Royal Free & University College Medical School in London. He played a major role in developing CytRx's lead small molecule drug candidate arimoclomol, according to the company.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.